Log in or Sign up for Free to view tailored content for your specialty!
Menopause News
Tool may predict premature menopause among childhood cancer survivors
A multi-institutional team of researchers created a statistical model capable of predicting the risk for premature menopause among women who survived childhood cancer.
Survey: Menopause symptoms disrupt work life for more than three-quarters of women
Menopause symptoms substantially impact work life for more than three-quarters of women, highlighting the need for more awareness and implementation of menopause support measures in the workplace, researchers reported in Menopause.
Log in or Sign up for Free to view tailored content for your specialty!
Effects of menopausal hormone therapy vary after age 65 years
Outcomes of using menopausal hormone therapy beyond age 65 years varied based on hormone therapy types, administration and strengths among women on Medicare, researchers reported in Menopause.
Earlier menopause transition negatively impacts work life
Earlier menopause — by age 46 years — was tied to worse self-perceived work ability, long-term work participation impairment and higher disability retirement risk, according to study data from women in Finland published in Menopause.
Menopause transition does not increase risk for depressive symptoms for all women
Women are not universally at risk for depressive symptoms during menopause transition, but providers should be aware of risk factors and treat mental health disorders promptly, according to a review published in The Lancet.
Sedentary time, physical activity tied to menopausal hot flash experiences
Sedentary time and physical activity were both associated with how menopausal women experience hot flashes, according to an analysis published in Menopause.
Non-hormone drugs can reduce menopausal hot flash frequency, severity
Fezolinetant and elinzanetant are both promising nonhormone therapies for managing vasomotor symptoms among postmenopausal women, with favorable safety profiles for up to 12 weeks, according to a systematic review published in Menopause.
Elinzanetant significantly reduces menopausal hot flash frequency
Once-daily oral elinzanetant was associated with significantly reduced frequency of moderate to severe menopausal vasomotor symptoms compared with placebo, according to topline results from the OASIS 3 study.
Hormone therapy may boost weight loss for postmenopausal women on semaglutide
Hormone therapy was associated with an improved weight-loss response for postmenopausal women with overweight or obesity treated with semaglutide, according to cohort study results published in Menopause.
Pairing podcasts with discussions in medical curriculums improves menopause knowledge
Curriculums that paired several podcast episodes with case-based classroom discussions improved preparation and knowledge on menopause among OB/GYN, family medicine and internal medicine specialists, researchers reported in Menopause.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read